Inventor

ROEMISCH JUERGEN

DE36 patents

⚠️ This page may combine multiple inventors who share the name “ROEMISCH JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROEMISCH JUERGEN

AVENTIS BEHRING GMBH

Stabilized protein preparation and process for its preparation

Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura

Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography

Protease for activating clotting factor VII

Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography

Process for quantifying glycosaminoglycans in antithrombin III-containing solutions

Mutants of the factor VII-activating protease and detection methods using specific antibodies

Process for dissolving albumin flakes in a liquid and arrangement for carrying out the process

Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis

Process for purifying factor VII and activated factor VII

Monoclonal antibody which is specific for activated coagulation factor VII, and its use

Process for separating HIV from a fluid

Stabilized antithrombin III preparation

Separation of antithrombin III α and β variants by cyclodextrin-modified micellar electrokinetic chromatography

Pharmaceutical preparation for the treatment of inflammatory processes

Pharmaceutical preparation for the treatment of inflammatory processes

Process for the preparation of a protein solution

CSL BEHRING GMBH

Methods of treatment involving the protease for activating clotting factor VII

Mutants of the factor VII-activating protease and detection methods using specific antibodies

Mutants of the factor VII-activating protease and detection methods using specific antibodies

Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations

Inhibitory monoclonal antibody against blood clotting factor VII-activating protease

Procedure for the determination of the activity of the protease which activates factor VII from protein solutions

BEHRINGWERKE AG

Method for the determination of antibodies against lipocortins

Process for removing toxins from protein solutions

Method for stabilizing annexins

Method for the purification of factor XIII by affinity chromatography

ZLB BEHRING GMBH

Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme

Protease for activating clotting factor VII

Monoclonal antibody which is specific for activated coagulation factor VII, and its use

OCTAPHARMA AG

Method of providing a purified, virus safe antibody preparation

BEHRING DIAGNOSTICS GMBH

Method for reproducibly determining the components of lacrimal fluid

BJORNSTRUP KIM

Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid

CENTEON PHARMA GMBH

Method for the quantification of activated coagulation factor VII (FVIIa)

DELTA BIOTECHNOLOGY LTD

Process for the separation of glycosylated and nonglycosylated proteins

BRANDSTAETTER HUBERT

Method for purification of complement factor H